How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 5, 2015, Pages 917-925

  Hammarstrom H ^a   Kondori, N ^a   Friman, V ^a   Wenneras C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN;

ADOLESCENT; ADULT; AGED; BLOOD; CHEMISTRY; COMPLICATION; DIAGNOSTIC TEST; EVALUATION STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; MYCOSES; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERUM; STATISTICAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BETA-GLUCANS; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC TESTS, ROUTINE; FALSE POSITIVE REACTIONS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM; YOUNG ADULT;

EID: 84939989454     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2302-9     Document Type: Article

References (49)

1. Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Martin PJ, Storb RF, Marr KA (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102(3):827–833. doi:10.1182/blood-2003-02-0456
2. Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T (2012) Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 96(6):748–757. doi:10.1007/s12185-012-1210-y
3. Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, Cappellano P, Fertrin KY, Carlesse F, Simões B, Bergamasco MD, Cunha CA, Seber A, Ribeiro MP, Queiroz-Telles F, Lee ML, Chauffaille ML, Silla L, de Souza CA, Colombo AL (2013) Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 19(8):745–751. doi:10.1111/1469-0691.12002
4. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91(8):1068–1075
5. Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45(9):1161–1170. doi:10.1086/522189
6. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48(3):265–273. doi:10.1086/595846
7. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47(9):1176–1184. doi:10.1086/592255
8. Chryssanthou E, Kalin M, Engervall P, Petrini B, Björkholm M (1998) Low incidence of candidaemia among neutropenic patients treated for haematological diseases. Scand J Infect Dis 30(5):489–493
9. Simoneau E, Kelly M, Labbe AC, Roy J, Laverdière M (2005) What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant 35(3):303–306. doi:10.1038/sj.bmt.1704793
10. Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP (2003) Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119(6):854–858. doi:10.1309/exbv-yaup-enbm-285y
11. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821. doi:10.1086/588660
12. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S; European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups (2012) ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 47(6):846–854. doi:10.1038/bmt.2011.178
13. Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, Klingspor L (2008) Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 57(Pt 3):287–295. doi:10.1099/jmm.0.47479-0
14. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I (2009) Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47(1):129–133. doi:10.1128/jcm.00506-08
15. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39(2):199–205. doi:10.1086/421944
16. Pazos C, Pontón J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299–305. doi:10.1128/jcm.43.1.299-305.2005
17. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH (2005) Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41(5):654–659. doi:10.1086/432470
18. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O; Third European Conference on Infections in Leukemia (ECIL-3) (2012) beta-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54(5):633–643. doi:10.1093/cid/cir897
19. Tamura H, Tanaka S, Oda T, Uemura Y, Aketagawa J, Hashimoto Y (1996) Purification and characterization of a (1-->3)-beta-D-glucan-binding protein from horseshoe crab (Tachypleus tridentatus) amoebocytes. Carbohydr Res 295:103–116
20. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR (2006) Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 50(10):3450–3453. doi:10.1128/aac.00658-06
21. Mennink-Kersten MA, Warris A, Verweij PE (2006) 1,3-beta-D-glucan in patients receiving intravenous amoxicillin–clavulanic acid. N Engl J Med 354(26):2834–2835. doi:10.1056/NEJMc053340
22. Ikemura K, Ikegami K, Shimazu T, Yoshioka T, Sugimoto T (1989) False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol 27(9):1965–1968
23. Nagasawa K, Yano T, Kitabayashi G, Morimoto H, Yamada Y, Ohata A, Usami M, Horiuchi T (2003) Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Organs 6(1):49–54. doi:10.1007/s100470300008
24. Ogawa M, Hori H, Niiguchi S, Azuma E, Komada Y (2004) False-positive plasma (1-->3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient. Int J Hematol 80(1):97–98
25. Ohata A, Usami M, Horiuchi T, Nagasawa K, Kinoshita K (2003) Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production. Artif Organs 27(8):728–735
26. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S (2002) Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 42(9):1189–1195
27. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10(5):882–885
28. Mennink-Kersten MA, Ruegebrink D, Verweij PE (2008) Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. Clin Infect Dis 46(12):1930–1931. doi:10.1086/588563
29. Kimura Y, Nakao A, Tamura H, Tanaka S, Takagi H (1995) Clinical and experimental studies of the limulus test after digestive surgery. Surg Today 25(9):790–794
30. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H (1997) False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 44(17):1413–1418
31. Kanda H, Kubo K, Hamasaki K, Kanda Y, Nakao A, Kitamura T, Fujita T, Yamamoto K, Mimura T (2001) Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level. Kidney Int 60(1):319–323. doi:10.1046/j.1523-1755.2001.00802.x
32. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A (2001) Elevation of blood (1-->3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 89(1):15–19. doi:10.1159/000046037
33. Yoshioka T, Ikegami K, Ikemura K, Shiono S, Uenishi M, Sugimoto H, Sugimoto T (1989) A study on limulus amebocyte lysate (LAL) reactive material derived from dialyzers. Jpn J Surg 19(1):38–41
34. Metan G, Ağkuş C, Buldu H, Koç AN (2010) The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections. Infection 38(3):217–221. doi:10.1007/s15010-010-0003-6
35. Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA (2012) Does ampicillin–sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses 55(4):366–371. doi:10.1111/j.1439-0507.2011.02131.x
36. Metan G, Koc AN, Ağkuş Ç, Kaynar LG, Alp E, Eser B (2012) Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Rev Iberoam Micol 29(3):169–171. doi:10.1016/j.riam.2011.07.003
37. Racil Z, Kocmanova I, Toskova M, Winterova J, Lengerova M, Timilsina S, Mayer J (2013) Reactivity of the 1,3-beta-D-glucan assay during bacteraemia: limited evidence from a prospective study. Mycoses 56(2):101–104. doi:10.1111/j.1439-0507.2012.02210.x
38. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J (2010) Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies—high frequency of false-positive results and their analysis. J Med Microbiol 59(Pt 9):1016–1022. doi:10.1099/jmm.0.019299-0
39. Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L (2006) Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 44(3):267–272. doi:10.1080/13693780500474327
40. Acosta J, Catalan M, del Palacio-Peréz-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1-->3)-beta-d-glucan chromogenic assay in serum sample. Clin Microbiol Infect 17(7):1053–1060. doi:10.1111/j.1469-0691.2010.03357.x
41. Alam FF, Mustafa AS, Khan ZU (2007) Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 7:103. doi:10.1186/1471-2334-7-103
42. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A (2008) Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 46(3):1009–1013. doi:10.1128/jcm.02091-07
43. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43(12):5957–5962. doi:10.1128/jcm.43.12.5957-5962.2005
44. De Vlieger G, Lagrou K, Maertens J, Verbeken E, Meersseman W, Van Wijngaerden E (2011) Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J Clin Microbiol 49(11):3783–3787. doi:10.1128/jcm.00879-11
45. Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 49(11):1650–1659. doi:10.1086/647942
46. Narta UK, Kanwar SS, Azmi W (2007) Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol 61(3):208–221. doi:10.1016/j.critrevonc.2006.07.009
47. Oettgen HF, Stephenson PA, Schwartz MK, Leeper RD, Tallai L, Tan CC, Clarkson BD, Golbey RB, Krakoff IH, Karnofsky DA, Murphy ML, Burchenal JH (1970) Toxicity of E. coli L-asparaginase in man. Cancer 25(2):253–278
48. Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, Brunzell JD, Otvos JD, Sallan SE, Rifai N (1997) Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 89(6):1886–1895
49. Sendid B, Francois N, Decool V, Poissy J, Poulain D (2013) Strategy for overcoming serum interferences in detection of serum (1,3)-beta-D-glucans. J Clin Microbiol 51(1):375–376. doi:10.1128/jcm.02356-12